About TECTRAUM, INC.
TecTraum Inc. has developed pro2cool®, a medical device designated as a Breakthrough Device by the FDA for treating concussions using hypothermic therapy. The device is currently investigational and has not yet received market authorization.
Hypothermic therapy for concussion treatmentNon-invasive and easy-to-use point-of-care delivery systemPortable and deployable in various settings including emergency rooms, doctor’s offices, and school facilitiesPotential for clinically significant improvements in mild traumatic brain injury (mTBI) patients
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TECTRAUM, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.